[EN] 2-AMIDO-4-ARYLOXY-1-CARBONYLPYRROLIDINE DERIVATIVES AS INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE [FR] INHIBITEURS DES SERINES PROTEASES, EN PARTICULIER DE LA PROTEASE NS3-NS4A DU VIRUS DE L'HEPATITE C (VHC)
[EN] 2-AMIDO-4-ARYLOXY-1-CARBONYLPYRROLIDINE DERIVATIVES AS INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE [FR] INHIBITEURS DES SERINES PROTEASES, EN PARTICULIER DE LA PROTEASE NS3-NS4A DU VIRUS DE L'HEPATITE C (VHC)
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
申请人:Perni Robert B.
公开号:US20080311079A1
公开(公告)日:2008-12-18
The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.
INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
申请人:Perni Robert B.
公开号:US20110104115A1
公开(公告)日:2011-05-05
The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.